Biological and Pharmaceutical Bulletin p. 1076 - 1081 (1997)
Update date:2022-07-29
Topics:
Ohta, Akihiro
Takahashi, Hiromitsu
Miyata, Naoomi
Hirono, Hiroyuki
Nishio, Toyotaka
Uchino, Etsuo
Yamada, Kenji
Aoyagi, Yutaka
Suwabe, Yasushi
Fujitake, Masayuki
Suzuki, Takahiro
Okamoto, Kazuo
This report describes the anti-platelet aggregation activity of 48 pyrazines. Among alkyl- and arylpyrazines tested, 2,3-diphenylpyrazines showed the strongest anti-platelet aggregation activity. Then, various substituents were introduced into the phenyl groups, and the 2,3-bis(p- methoxyphenyl)pyrazine derivatives were consequently found to possess considerably strong inhibitory activity.
View MoreJinan Hongfangde Pharmatech Co.,Ltd
Contact:86-531-88870908
Address:F Bldg. West Unit North Area of Univ. Tech. Garden Xinyu Rd. Jinan New & High Tech Industry Development Zone Shandong, China
website:http://www.uvchemkeys.com
Contact:0086-021-58785816
Address:RM2607 Building No.1 Guosheng, Lane 388, Zhongjiang Road, Putuo District, Shanghai 200062 China
Xi'an yuanfar international trade company
website:https://www.yuanfarchemical.com
Contact:86-029-88745613 ext 828
Address:Floor19th ,B Building, Oak Block,No.36 South Fenghui Road, Dev. Zone of High-Tech Ind.,Xi’an, China
Nanjing Habo Medical Technology Co., Ltd.
Contact:025－85769882
Address:No.108. Ganjiabian east. Qixia District .Nanjing
Contact:17316303296
Address:240 Amboy Ave
Doi:10.1055/s-2008-1077824
(2008)Doi:10.1055/s-2005-868514
(2005)Doi:10.1039/c8ob01868e
(2018)Doi:10.1016/S0040-4039(00)60871-7
(1992)Doi:10.1016/j.saa.2011.03.022
(2011)Doi:10.1021/jo01129a015
(1953)
